{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:20:41Z","timestamp":1777879241992,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1312201"],"award-info":[{"award-number":["2018YFC1312201"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC81872475"],"award-info":[{"award-number":["NSFC81872475"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC82073345"],"award-info":[{"award-number":["NSFC82073345"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.clon.2022.01.002","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T14:11:23Z","timestamp":1642601483000},"page":"e238-e245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pre-treatment 18F-RGD Uptake may Predict Adverse Events during Apatinib Antiangiogenic Therapy"],"prefix":"10.1016","volume":"34","author":[{"given":"L.","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.-M.","family":"(Spring) Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2022.01.002_bib1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat Med"},{"issue":"Suppl. 1","key":"10.1016\/j.clon.2022.01.002_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1634\/theoncologist.9-suppl_1-2","article-title":"Vascular endothelial growth factor as a target for anticancer therapy","volume":"9","author":"Ferrara","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.clon.2022.01.002_bib3","series-title":"Mechanisms of angiogenesis. Experientia supplementum","first-page":"209","article-title":"The role of VEGF in the regulation of physiological and pathological angiogenesis","author":"Ferrara","year":"2005"},{"key":"10.1016\/j.clon.2022.01.002_bib4","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1200\/JCO.1997.15.2.826","article-title":"Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma","volume":"15","author":"Tanigawa","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.01.002_bib5","first-page":"123","article-title":"Clinical advances in the development of novel VEGFR2 inhibitors","volume":"2","author":"Fontanella","year":"2014","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.clon.2022.01.002_bib6","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1200\/JCO.2019.37.15_suppl.9112","article-title":"Efficacy of PD-1 monoclonal antibody SHR-1210 plus apatinib in patients with advanced nonsquamous NSCLC with wild-type EGFR and ALK","volume":"37","author":"Zhou","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.01.002_bib7","doi-asserted-by":"crossref","first-page":"S439","DOI":"10.1016\/j.jtho.2019.08.905","article-title":"Efficacy and safety of sintilimab with anlotinib as first-line therapy for advanced non-small cell lung cancer (NSCLC)","volume":"14","author":"Han","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.clon.2022.01.002_bib8","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2013.48.8585","article-title":"Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial","volume":"31","author":"Li","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2022.01.002_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2016.01.014","article-title":"Apatinib: a novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer","volume":"372","author":"Roviello","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clon.2022.01.002_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrc727","article-title":"Role of integrins in cell invasion and migration","volume":"2","author":"Hood","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clon.2022.01.002_bib11","doi-asserted-by":"crossref","first-page":"21785","DOI":"10.1074\/jbc.R000003200","article-title":"Ligand binding to integrins","volume":"275","author":"Plow","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clon.2022.01.002_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1126\/science.1069040","article-title":"Crystal structure of the extracellular segment of integrin \u03b1V\u03b23 in complex with an Arg-Gly-Asp ligand","volume":"296","author":"Xiong","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.clon.2022.01.002_bib13","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.biomaterials.2013.10.072","article-title":"Molecular basis for the targeted binding of RGD-containing peptide to integrin \u03b1V\u03b23","volume":"35","author":"Yu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.clon.2022.01.002_bib14","first-page":"763","article-title":"PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging \u03b1v\u03b23 expression","volume":"47","author":"Beer","year":"2006","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.clon.2022.01.002_bib15","first-page":"S245","article-title":"Role of alpha v integrins during angiogenesis","volume":"6","author":"Eliceiri","year":"2000","journal-title":"Cancer J"},{"key":"10.1016\/j.clon.2022.01.002_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.7512751","article-title":"Requirement of vascular integrin alpha v beta 3 for angiogenesis","volume":"264","author":"Brooks","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.clon.2022.01.002_bib17","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s00259-018-4143-8","article-title":"Pretreatment PET\/CT imaging of angiogenesis based on 18 F-RGD tracer uptake may predict antiangiogenic response","volume":"46","author":"Li","year":"2019","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.clon.2022.01.002_bib18","volume":"vol. 4","author":"Health UDo","year":"2009"},{"key":"10.1016\/j.clon.2022.01.002_bib19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2967\/jnumed.112.113563","article-title":"First experience of 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination","volume":"54","author":"Wan","year":"2013","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.clon.2022.01.002_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1389450033346830","article-title":"Integrin \u03b1v\u03b23 as a therapeutic target for blocking tumor-induced angiogenesis","volume":"4","author":"Kumar","year":"2003","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.clon.2022.01.002_bib21","doi-asserted-by":"crossref","first-page":"L344","DOI":"10.1152\/ajplung.00291.2003","article-title":"Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor","volume":"287","author":"Tang","year":"2004","journal-title":"Am J Physiol Lung C"},{"key":"10.1016\/j.clon.2022.01.002_bib22","series-title":"Oxygen transport to tissue XII","first-page":"895","article-title":"Blood flow, oxygen consumption and tissue oxygenation of human tumors","volume":"vol. 277","author":"Vaupel","year":"1990"},{"key":"10.1016\/j.clon.2022.01.002_bib23","first-page":"1408","article-title":"The unique physiology of solid tumors: opportunities (and problems) for cancer therapy","volume":"58","author":"Brown","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.clon.2022.01.002_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655522000176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655522000176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:38:32Z","timestamp":1777592312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655522000176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0936655522000176"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2022.01.002","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-treatment 18F-RGD Uptake may Predict Adverse Events during Apatinib Antiangiogenic Therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2022.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}